2906
Z. Lei et al. / Tetrahedron: Asymmetry 11 (2000) 2899±2906
15
Compound 16d: m.p. 104±106ꢀC. ꢁ +124.0 (c 0.075, MeOH). UV lMmaexOH (lg "): 272.7 (4.03).
D
1H NMR (300 MHz, DMSO-d6) ꢀ: 3.36 (m, 2H), 3.53 (m, 2H), 4.13 (m, 2H), 4.53 (m, D2O
exchangeable, 1H), 4.65 (m, t after D2O exchange, 1H, H-3), 4.85 (overlapped, 2H, H-4, OH),
5.48 (d, J=5.1 Hz, 1H, D2O exchangeable, 3-OH), 7.88 (d, J=7.8 Hz, 1H, H-60), 11.85 (d, J=5.1
Hz, 1H, D2O exchangeable, NH). CI-MS m/z: 277 [M+H]+. HRMS (FAB) calcd. for
C10H13N2O6F: [M+H]Á277.0830. Found: 277.0821.
Acknowledgements
This work was supported by the National Natural Science Foundation of China and by a grant
(G 1998051103) from the Ministry of Science and Technology of China.
References
1. (a) DeClercq, E. In Approaches to Antiviral Agents; Harnden, M. H., Ed.; VCH: Deer®eld Park, FL, 1985; pp. 57±
99; (b) DeClercq, E. Nucleosides & Nucleotides 1987, 1189; (c) Diana, G. C.; Pevear, D.; Young, D. C. Ann. Rep.
Med. Chem. 1989, 24, 129; (d) Schaeer, H. J.; Beauchamp, L.; Miranda, P.; Elion, G. B.; Bauer, D. J.; Collins, P.
Nature 1978, 272, 583; (e) Vince, R.; Hua, M.; Brownell, J.; Daluge, S.; Lee, F.; Shannon, W. M.; Lavelle, G. C.;
Qualls, J.; Weislow, O. S.; Kiser, R.; Canonico, P. G.; Schultz, R. H.; Narayanan, V. L.; Mayo, J. G.; Shoemaker,
R. H.; Boyd, M. R. Biochem. Biophys. Res. Commun. 1988, 156, 1046; (f) Hoshino, H.; Shimizu, N. J. Antibiot.
1987, 40, 1077.
2. Masuda, A.; Kitagawa, M.; Tanaka, A.; Saito, S.; Shimade, N.; Ikeda, R.; Hoshino, H.; Daikoku, T.; Nishiyama,
Y. J. Antibiot. 1993, 46, 1034.
3. (a) Branalt, J.; Kvarnstrom, I.; Classon, B. J. Org. Chem. 1996, 61, 3599; (b) Ichikawa, E.; Yamamura, S; Kato,
K. Bioorg. and Med. Chem. Lett. 1999, 9, 1113; (c) Ichikawa, E.; Yamamura, S.; Kato, K. Teteahedron Lett. 1999,
40, 7385; (d) Bamford, M. J.; Coe, P. L.; Walker, R. T. J. Med. Chem. 1990, 33, 2494.
4. Acton, E. M.; Goerner, R. N.; Uh, H. S.; Ryan, K. J.; Henry, D. W. J. Med. Chem. 1997, 22, 518.
5. (a) Soike, K. F.; Whiterock, V. J. Antiviral Res. 1994, 23, 219; (b) Jones, M. F.; Noble, S. A.; Roberston, C. A.;
Storer, R.; Highcock, R. M.; Lamont, R.B. J. Chem. Soc., Perkin Trans. 1 1992, 1427; (c) Nair, V. Nucleosides and
Nucleotides as Antitumor and Antiviral Agents; Chu, C. K.; Baker, D. C., Eds.; Plenum Press: New York, 1993; p.
127; (d) Verheggen, I.; Van Aerschot, A.; Toppet, S.; Snoeck, R.; Janssen, G.; Balzarini, J.; De Clercq, E.;
Herdewijn, P. J. Med. Chem. 1993, 36, 2033; (e) Nair, V.; Jahnke, T. S. Antimicrob. Agents Chemother. 1995, 39,
1017; (f) Prevost, N.; Rouessac, F. Synth. Commun. 1997, 27, 2325; (g) Jung, M. E.; Nichols, C. J. J. Org. Chem.
1998, 63, 347.
6. (a) Nair, V.; Nuesca, Z. M. J. Am. Chem. Soc. 1992, 114, 7951; (b) Bolon, P. J.; Sells, T. B.; Nuesca, Z. M.; Purdy,
D. F.; Nair, V. Tetrahedron 1994, 50, 7747; (c) Diaz, Y.; Bravo, F.; Castillon, S. J. Org. Chem. 1999, 64, 6508.
7. (a) Huryn, D. M.; Sluoski, B. C.; Tam, S. Y.; Todaro, L. J.; Weigele, M. Tetrahedron Lett. 1989, 30, 6259; (b)
Huryn, D. M.; Sluboski, B. C.; Tam, S. Y.; Weigele, M.; Sim, Iain; Anderson, B. D.; Mitsuya, H.; Broder, S.
J. Med. Chem. 1992, 35, 2347; (c)Jung, M. E.; Kretschik, O. J. Org. Chem. 1998, 63, 2975.
8. (a) Yang, Z. J.; Yu, H. W.; Min, J. M.; Ma, L. T.; Zhang, L. H. Tetrahedron: Asymmetry 1997, 8, 2739; (b) Yu,
H. W.; Zhang, H. Y.; Yang, Z. J.; Min, J. M.; Ma, L. T.; Zhang, L. H. Pure Appl. Chem. 1998, 70, 435.
9. Defaye, J. Advan. Carbohyd. Chem. and Biochem. 1970, 25, 183.
10. Horton, D.; Philips, K. D. Methods Carbohyd. Chem. 1976, 7, 68.
11. (a) Mitsunobu, O. Synthesis 1981, 1; (b) Chen, Y.-C. J.; Hansske, F.; Janda, K. D.; Robins, M. J. J. Org. Chem.
1991, 56, 3410.